We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 50

Snapshot of Sunshine rules in EU countries for the pharmaceutical industry part 1 - June 2014

  • McDermott Will & Emery
  • -
  • European Union, United Kingdom
  • -
  • June 12 2014

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. In 2013

The extent of supply limitation on EU pharmaceutical trade

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • December 16 2008

In its 16 September 2008 judgment, the European Court of Justice (ECJ) gave further guidance on how a dominant pharmaceutical supplier can justify limiting supplies to wholesalers

European Commission fines pharmaceutical companies for Citalopram pay-for-delay agreements

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • June 30 2013

On 19 June 2013, the European Commission announced a fine of 93.8 million for H. Lundbeck AS (Lundbeck) and a further 52.2 million of fines levied

Are supplementary protection certificates keeping pace with drug development?

  • McDermott Will & Emery
  • -
  • European Union, United Kingdom
  • -
  • April 10 2007

The pharmaceutical and biotechnology industries are heavily dependent on patents as a means of securing future revenues

Advocate General Jääskinen gives Georgetown University SPC opinion

  • McDermott Will & Emery
  • -
  • European Union, Netherlands, United Kingdom
  • -
  • December 16 2013

On 14 November 2013, Advocate General (AG) Jääskinen's opinion in the Dutch supplementary protection certificate (SPC) referral, Georgetown

Controlling and processing data in EU clinical trials

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • November 22 2010

The legal regime for the conduct of clinical trials of medicinal products for human use in the European Union is set out in Directive 200120EC (the Clinical Trials Directive

Increased European patent protection following a landmark ruling on supplementary protection certificates

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • August 30 2012

The Court of Justice of the European Union (CJEU) rendered judgment relating to a preliminary reference from the English Court of Appeal, holding that the existence of an earlier marketing authorization (MA) of a pharmaceutical product does not preclude the grant of a Supplementary Protection Certificate (SPC) for a different application of the same product

New move to create internal market for health care services

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • October 5 2007

The European Commission is drafting a directive to ensure the protection of patients’ basic rights when travelling to other EU Member States to receive medical treatment

Commission publishes fourth monitoring report on pharmaceutical patent settlements

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • February 11 2014

The European Commission has published its fourth Report on the Monitoring of Patent Settlements (the report), concerning pharmaceutical patent

Mergers: Commission approves Nestlé’s acquisition of Novartis' Medical Nutrition business

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • July 6 2007

The European Commission has cleared the merger of Nestlé S.A. and Novartis' Medical Nutrition business (NMN) following a first phase investigation